Insulet Corporation(PODD)

Sector:

Healthcare

Description:

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Current Price

$281.03

RSI

43.92

Market Capitalization:

17.5B

Beta:

0.671

Volume:

687,048

Analyst Target Price:

$ 294

Economiic Fair Price:


November 03, 2022
November 04, 2022
Q3
N/A
N/A
N/A
N/A
N/A
721.5M
1.4B
0.24
1.53 %
16.23
0.029

19.88 %
2445.65 %
109.13 %
23.66 %
-137.50 %
141.45 %

$ 1.1B
21.49 %
$ 904.4M
22.51 %
$ 738.2M
30.93 %
$ 563.8M
21.57 %
$ 463.8M
26.37 %
$ 367M

$ -190.8M
-131.27 %
$ -82.5M
-13.79 %
$ -72.5M
42.67 %
$ -126.5M
-251.08 %
$ -36M
-480.58 %
$ -6.2M

$ 20.5M
111.34 %
$ 9.7M
-33.10 %
$ 14.5M
177.46 %
$ 5.2M
119.67 %
$ -26.6M
0.91 %
$ -26.8M

News

Press Releases

Notable Dates